메뉴 건너뛰기




Volumn 368, Issue 9537, 2006, Pages 714-716

Anaemia, parvovirus, and malaria

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAMPLING; DISEASE SEVERITY; ENDEMIC DISEASE; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRON DEFICIENCY ANEMIA; MALARIA; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 33747761322     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69265-9     Document Type: Note
Times cited : (2)

References (10)
  • 1
    • 0016413654 scopus 로고
    • Parvovirus-like particles in human sera
    • Cossart Y., Field A., Cant B., and Widdows D. Parvovirus-like particles in human sera. Lancet 1 (1975) 72-73
    • (1975) Lancet , vol.1 , pp. 72-73
    • Cossart, Y.1    Field, A.2    Cant, B.3    Widdows, D.4
  • 2
    • 0023925913 scopus 로고
    • The prevalence of antibody to human parvovirus B19 in England and Wales
    • Cohen B., and Buckley M. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 25 (1988) 151-153
    • (1988) J Med Microbiol , vol.25 , pp. 151-153
    • Cohen, B.1    Buckley, M.2
  • 3
    • 1442334131 scopus 로고    scopus 로고
    • Parvovirus B19
    • Young N., and Brown K. Parvovirus B19. N Engl J Med 350 (2004) 586-597
    • (2004) N Engl J Med , vol.350 , pp. 586-597
    • Young, N.1    Brown, K.2
  • 4
    • 0021790511 scopus 로고
    • Experimental parvoviral infection in humans
    • Anderson M., Higgins P., Davis L., et al. Experimental parvoviral infection in humans. J Infect Dis 152 (1985) 257-265
    • (1985) J Infect Dis , vol.152 , pp. 257-265
    • Anderson, M.1    Higgins, P.2    Davis, L.3
  • 5
    • 0023184712 scopus 로고
    • Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19)
    • Potter C., Potter A., Hatton C., et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest 79 (1987) 1486-1492
    • (1987) J Clin Invest , vol.79 , pp. 1486-1492
    • Potter, C.1    Potter, A.2    Hatton, C.3
  • 6
    • 0019512232 scopus 로고
    • Outbreak of aplastic crisis in sickle cell anaemia associated with parvovirus-like agent
    • Serjeant G., Topley J., Mason K., et al. Outbreak of aplastic crisis in sickle cell anaemia associated with parvovirus-like agent. Lancet 2 (1981) 595-597
    • (1981) Lancet , vol.2 , pp. 595-597
    • Serjeant, G.1    Topley, J.2    Mason, K.3
  • 7
    • 0025022768 scopus 로고
    • Human parvovirus infection in children and severe anaemia seen in an area endemic for malaria
    • Jones P., Pickett L., Anderson M., and Pasvol G. Human parvovirus infection in children and severe anaemia seen in an area endemic for malaria. J Trop Med Hyg 93 (1990) 67-70
    • (1990) J Trop Med Hyg , vol.93 , pp. 67-70
    • Jones, P.1    Pickett, L.2    Anderson, M.3    Pasvol, G.4
  • 8
    • 33746172965 scopus 로고    scopus 로고
    • Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea
    • Wildig J., Michon P., Siba P., et al. Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis 194 (2006) 146-153
    • (2006) J Infect Dis , vol.194 , pp. 146-153
    • Wildig, J.1    Michon, P.2    Siba, P.3
  • 9
    • 0033870016 scopus 로고    scopus 로고
    • The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world
    • Kelly H., Siebert D., Hammond R., Leydon J., Kiely P., and Maskill W. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 124 (2000) 449-457
    • (2000) Epidemiol Infect , vol.124 , pp. 449-457
    • Kelly, H.1    Siebert, D.2    Hammond, R.3    Leydon, J.4    Kiely, P.5    Maskill, W.6
  • 10
    • 0037442784 scopus 로고    scopus 로고
    • Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1
    • Ballou W., Reed J., Noble W., Young N., and Koenig S. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Infect Dis 187 (2003) 675-678
    • (2003) J Infect Dis , vol.187 , pp. 675-678
    • Ballou, W.1    Reed, J.2    Noble, W.3    Young, N.4    Koenig, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.